Remove 2016 Remove Leads Remove Networking Remove Pharmaceutical manufacturing
article thumbnail

Strategies for Combination Therapy in Oncology: Part One – Business as Usual

PM360

Combination Therapy in Oncology Combination therapies comprising two or more therapeutic agents have become a cornerstone of oncology management and are increasingly a development focus for the pharmaceutical industry. Between May 1, 2016, and May 31, 2021, 42% of all U.S. JAMA Network Open 5 , no. Certain markets (e.g.,